Péter Reismann
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Advanced Glycation End Products research
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- Metabolism and Genetic Disorders 13
- Advanced Glycation End Products research 6
-
- Mitochondrial Function and Pathology 7
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Gottfried Rudofsky (9 shared papers)Angelika Bierhaus (8 shared papers)A. Hamann (7 shared papers)Attila Patócs (10 shared papers)Peter P. Nawroth (6 shared papers)Kàroly Rácz (7 shared papers)Péter Igaz (6 shared papers)Per M. Humpert (3 shared papers)
- Journals
- Hormone and Metabolic Research (3 papers)Experimental and Clinical Endocrinology & Diabetes (3 papers)Annals of Nutrition and Metabolism (2 papers)Frontiers in Endocrinology (2 papers)Mini-Reviews in Medicinal Chemistry (1 paper)
- Partner nations
- HungaryGermanySwitzerland
In The Last Decade
Péter Reismann
40 papers receiving 633 citations
Peers
Comparison fields: 5 of 79
- Clinical Biochemistry 152
- Cancer Research 159
- Endocrinology, Diabetes and Metabolism 151
- Immunology 124
- Physiology 142
Countries citing papers authored by Péter Reismann
This map shows the geographic impact of Péter Reismann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Reismann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Reismann more than expected).
Fields of papers citing papers by Péter Reismann
This network shows the impact of papers produced by Péter Reismann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Reismann. The network helps show where Péter Reismann may publish in the future.
Co-authors
The 25 scholars most cited alongside Péter Reismann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 146 | |
| 2 | 2004 | 82 | |
| 3 | 2014 | 53 | |
| 4 | 2004 | 48 | |
| 5 | 2004 | 47 | |
| 6 | 2013 | 25 | |
| 7 | 2018 | 24 | |
| 8 | 2012 | 22 | |
| 9 | 2019 | 20 | |
| 10 | 2009 | 19 | |
| 11 | 2004 | 14 | |
| 12 | 2020 | 14 | |
| 13 | 2011 | 13 | |
| 14 | 2020 | 10 | |
| 15 | 2009 | 10 | |
| 16 | 2007 | 9 | |
| 17 | 2020 | 9 | |
| 18 | 2021 | 8 | |
| 19 | 2011 | 7 | |
| 20 | 2013 | 7 |
About Péter Reismann
Péter Reismann is a scholar working on Clinical Biochemistry, Molecular Biology, Physiology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 44 papers that have together received 654 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (13 papers), Diet and metabolism studies (9 papers), Mitochondrial Function and Pathology (7 papers), Advanced Glycation End Products research (6 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Adrenal and Paraganglionic Tumors (4 papers), Pituitary Gland Disorders and Treatments (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Clinical Biochemistry (152 citations), Cancer Research (159 citations), Endocrinology, Diabetes and Metabolism (151 citations), Immunology (124 citations) and Physiology (142 citations). Péter Reismann has collaborated with scholars based in Hungary, Germany and Switzerland. Frequent co-authors include Gottfried Rudofsky, Angelika Bierhaus, A. Hamann, Attila Patócs, Peter P. Nawroth, Kàroly Rácz, Péter Igaz, Per M. Humpert, Berend Isermann and István Likó. Their work appears in journals such as Hormone and Metabolic Research, Experimental and Clinical Endocrinology & Diabetes, Annals of Nutrition and Metabolism, Frontiers in Endocrinology and Mini-Reviews in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.